GTBP
GT Biopharma, Inc.
-0.75 (-9.63%)7.06USD82.2K成交股數318M市值1.6本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.1M | 413K | 1.4M | 634K | 363K | 1.1M | 1.3M | 1.8M | 777K | 1.4M | 1.4M | 2.1M |
| 銷售管理費用 | 3.5M | 2.4M | 4.2M | 2.7M | 1.2M | 833K | 2.3M | 2.1M | 2.3M | 1.8M | 1.8M | 1.5M |
| 營業利益 | −4.5M+198% | −2.8M+47% | −5.6M+55% | −3.4M-13% | −1.5M-51% | −1.9M-39% | −3.6M+15% | −3.9M+8% | −3.1M | −3.2M | −3.1M | −3.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −4.5M-85% | −2.8M+265% | −5.7M+67% | 8.3M-324% | −30.2M+1231% | −776K-74% | −3.4M+41% | −3.7M+86% | −2.3M | −3.0M | −2.4M | −2.0M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.12-99% | -0.11-67% | 3.53-331% | 1.04-148% | -10.92+566% | -0.33-85% | -1.53-14% | -2.17+46% | -1.64 | -2.17 | -1.77 | -1.49 |
| 稀釋股數 | 38.8M | 30.3M | 5.5M | 3.9M | 2.8M | 2.3M | 2.2M | 1.7M | 1.4M | 1.3M | 1.4M | 1.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 5.0M | 8.9M | 6.8M | 2.5M | 5.2M | 2.4M | 6.4M | 9.2M | 2.0M | 1.1M | 2.6M | 2.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | – | – | 8.1M | 4.3M | 7.1M | – | 6.8M | 9.3M | 9.9M | 14.1M | 16.1M | 18.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | – | – | – | 1.3M | 31.0M | – | – | – | 4.6M | 6.6M | 6.1M | 6.4M |
| 股東權益 | 3.6M | 7.6M | 5.8M | 3.0M | −25.9M | −980K | 2.1M | 5.5M | 5.3M | 7.5M | 10.0M | 11.8M |
| 負債比 | – | – | – | 30.6% | 435.8% | – | – | – | 46.4% | 47.0% | 38.0% | 35.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.5M+12% | – | – | – | −2.2M | – | – | −4.2M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −28.4M | –% | -6.68 | – |
| FY2024 | – | – | −13.2M | –% | -6.94 | – |
| FY2023 | – | – | −7.6M | –% | -5.64 | – |
| FY2022 | – | – | −20.9M | –% | -19.66 | – |
| FY2021 | – | – | −58.0M | –% | -2.06 | – |
| FY2020 | 0.00 | – | −28.3M | –% | -6.45 | – |
| FY2019 | 0.00 | – | −38.6M | –% | -0.01 | −3.7M |
| FY2018 | – | – | −259M | –% | -5.16 | −10.7M |